CF
PBMWW

Cantor Fitzgerald’s Psyence Biomedical Warrant PBMWW Stock Holding History

Cantor Fitzgerald’s Portfolio PBMWW Stock Details PBMWW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-468,500
Closed -$9.51K – 559
2025
Q2 		$9.51K Hold
468,500
– – ﹤0.01% 423
2025
Q1 		$7.92K Hold
468,500
– – ﹤0.01% 291
2024
Q4 		$5.62K Hold
468,500
– – ﹤0.01% 258
2024
Q3 		$5.9K Hold
468,500
– – ﹤0.01% 197
2024
Q2 		$4.92K Hold
468,500
– – ﹤0.01% 232
2024
Q1 		$59.9K Buy
+468,500
New +$29.2K 0.01% 178

Other funds holding PBMWW

HCI
Harraden Circle Investments New York $784M AUM 20.59% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Cantor Fitzgerald's PBMWW Position: Q3 2025 in Review

Cantor Fitzgerald sold out of Psyence Biomedical Warrant (PBMWW) in Q3 2025, closing a stake of 468,500 shares — an estimated $9.51K sold.

Cantor Fitzgerald first reported a position in PBMWW in Q1 2024 and held it in 6 quarters. The position peaked at $59.9K in Q1 2024. 23 funds tracked by Wall St. Rank hold PBMWW as of Q3 2025.

  • Cantor Fitzgerald reported no remaining Psyence Biomedical Warrant position as of Q3 2025 after selling out during the quarter.
  • Cantor Fitzgerald sold 468,500 Psyence Biomedical Warrant shares in Q3 2025, an estimated $9.51K.
  • Cantor Fitzgerald first reported a position in Psyence Biomedical Warrant in Q1 2024 and held it in 6 quarters.
  • Cantor Fitzgerald's Psyence Biomedical Warrant position peaked at $59.9K in Q1 2024.
  • 23 funds tracked by Wall St. Rank held Psyence Biomedical Warrant as of Q3 2025.

Based on Cantor Fitzgerald's 13F filing for Q3 2025, filed 14 Nov 2025.